Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Drug Discov Today ; 27(10): 103327, 2022 Oct.
Article in English | MEDLINE | ID: covidwho-1956122

ABSTRACT

Throughout 2021, the scientific and medical communities were concentrated on dealing with the acute morbidity and mortality induced by the COVID-19 pandemic due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We reviewed the present data for adverse effects of COVID-19 on the different parts of the male urogenital system during the dynamic situation of the COVID-19 pandemic. With the approval of COVID-19 vaccinations, there is a ray of hope at the end of this dark tunnel and a chance to look ahead for the management of long-term consequences in males with urogenital illness. A multidisciplinary investigation of these cases could provide information for establishing and optimizing treatment protocols.


Subject(s)
COVID-19 , Vaccines , Angiotensin-Converting Enzyme 2 , COVID-19/prevention & control , Humans , Male , Pandemics/prevention & control , Peptidyl-Dipeptidase A , SARS-CoV-2 , Urogenital System
SELECTION OF CITATIONS
SEARCH DETAIL